Diabetes

CLIFFSIDE PARK, N.J. The U.S. Patent and Trademark Office has granted a patent to the privately owned company Pop Test for a means for diabetics to measure their glucose levels without drawing blood, Pop Test said Tuesday.

The company said it is conducting clinical trials on a glucose test that uses saliva to allow Type 1 and Type 2 diabetes patients to monitor blood glucose, and can detect abnormally low and abnormally high blood sugar levels.

WASHINGTON Two companies announced the integration of their respective programs to develop an end-to-end wireless diabetes management solution.

SAN DIEGO The developer of a wireless mobile application designed to help manage diabetes announced that its program, which is downloaded every 29 seconds worldwide, is teaming up with a mobile phone manufacturer.

MISSISSAUGA, Ontario A new study conducted by University of Toronto researchers found that GLP-1 analogues not only help to lower blood-glucose levels, but also have the added benefit of reducing body mass index and waist circumference.

CAMBRIDGE, Mass. A company that develops drugs for treating autoimmune diseases and cancer has created a scientific advisory board as part of its efforts to create treatments for Type 1 diabetes.

Tolerx said the four-member board would support the development of its lead drug candidate, otelixizumab, and guide future research and development in the Type 1 diabetes area.